Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Supporting projects developing innovative technologies for biomedical research, advancing current capabilities for acquiring biomedical knowledge.
Funder: National Institutes of Health
Due Dates: May 7, 2025 (AIDS) | June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | and standard NIH cycles through January 7, 2028
Funding Amounts: No budget cap; budgets must reflect actual project needs. Up to 4 years for most, 5 years for Early-Stage Investigators. One renewal allowed.
Summary: Supports development of innovative technologies (not clinical trials) that enable acquisition of biomedical knowledge and advance the state of the art for broad biomedical research use.
Key Information: Applications must focus solely on technology development (not biological questions); clinical trials are not allowed.
Description
This opportunity, offered by the National Institute of General Medical Sciences (NIGMS) at NIH, supports research projects focused exclusively on the development of innovative technologies with the potential to broadly enable biomedical research. The goal is to advance technologies that have demonstrated proof-of-concept but require further development to reach a working prototype stage, overcoming significant technical hurdles. Projects must be justified by their technical innovation and their anticipated impact on future biomedical research.
Key points:
- Projects must focus solely on technology development (e.g., instruments, devices, algorithms, software, chemical reagents, or engineered biological systems).
- Applications proposing to use the technology to answer specific biological questions are not responsive and will be withdrawn.
- Incremental improvements or obvious extrapolations of existing technologies are a low funding priority.
- Clinical trials are not allowed.
